Literature DB >> 10095105

Organization of the gene for gelatin-binding protein (GBP28).

K Saito1, T Tobe, S Minoshima, S Asakawa, J Sumiya, M Yoda, Y Nakano, N Shimizu, M Tomita.   

Abstract

GBP28 is a novel human plasma gelatin-binding protein that is encoded by apM1 mRNA, expressed specifically in adipose tissue. Three overlapping clones (two lambda clones and one BAC clone) containing the human plasma gelatin-binding protein (GBP28) gene were isolated and characterized. The GBP28 gene spans 16kb and is composed of three exons from 18bp to 4277bp in size with consensus splice sites. The sizes of the two introns were 0.8 and 12kb, respectively. The gene's regulatory sequences contain putative promoter elements, but no typical TATA box. The third exon of this gene contains a long 3'-untranslated sequence containing three Alu repeats. The exon-intron organization of this gene was very similar to that of obese gene, encoding leptin. We also report the chromosome mapping of this gene by fluorescence in situ hybridization (FISH) using a genomic DNA fragment as a probe. The GBP28 gene was located on human chromosome 3q27. The nucleotide sequence data reported in this paper will appear in the DDBJ/EMBL/GenBank nucleotide sequence databases with the accession numbers ABO12163, ABO12164 or ABO12165.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10095105     DOI: 10.1016/s0378-1119(99)00041-4

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  21 in total

1.  Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome.

Authors:  A H Kissebah; G E Sonnenberg; J Myklebust; M Goldstein; K Broman; R G James; J A Marks; G R Krakower; H J Jacob; J Weber; L Martin; J Blangero; A G Comuzzie
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

Review 2.  Adipose tissue: the new endocrine organ? A review article.

Authors:  Susan E Wozniak; Laura L Gee; Mitchell S Wachtel; Eldo E Frezza
Journal:  Dig Dis Sci       Date:  2008-12-04       Impact factor: 3.199

3.  Association of ADIPOQ, leptin, LEPR, and resistin polymorphisms with obesity parameters in Hammam Sousse Sahloul Heart Study.

Authors:  Nesrine Zayani; Asma Omezzine; Imen Boumaiza; Ons Achour; Lamia Rebhi; Jihen Rejeb; Nabila Ben Rejeb; Ahmed Ben Abdelaziz; Ali Bouslama
Journal:  J Clin Lab Anal       Date:  2017-02-13       Impact factor: 2.352

Review 4.  Adiponectin and breast cancer.

Authors:  Xiuping Chen; Yitao Wang
Journal:  Med Oncol       Date:  2010-07-13       Impact factor: 3.064

Review 5.  The role of adiponectin in endothelial dysfunction and hypertension.

Authors:  Edward Rojas; Daloha Rodríguez-Molina; Peter Bolli; Zafar H Israili; Judith Faría; Enzamaría Fidilio; Valmore Bermúdez; Manuel Velasco
Journal:  Curr Hypertens Rep       Date:  2014-08       Impact factor: 5.369

Review 6.  Adiponectin action from head to toe.

Authors:  Karine Brochu-Gaudreau; Charlotte Rehfeldt; Richard Blouin; V Bordignon; Bruce D Murphy; Marie-France Palin
Journal:  Endocrine       Date:  2009-12-01       Impact factor: 3.633

7.  Application of back propagation artificial neural network on genetic variants in adiponectin ADIPOQ, peroxisome proliferator-activated receptor-γ, and retinoid X receptor-α genes and type 2 diabetes risk in a Chinese Han population.

Authors:  Hui Shi; Ying Lu; Juan Du; Wencong Du; Xinhua Ye; Xiaofang Yu; Jianhua Ma; Jinluo Cheng; Yanqin Gao; Yuanyuan Cao; Ling Zhou; Qian Li
Journal:  Diabetes Technol Ther       Date:  2011-10-24       Impact factor: 6.118

Review 8.  APPL1: role in adiponectin signaling and beyond.

Authors:  Sathyaseelan S Deepa; Lily Q Dong
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-14       Impact factor: 4.310

9.  Biomarkers of adiponectin: plasma protein variation and genomic DNA polymorphisms.

Authors:  Harvest F Gu
Journal:  Biomark Insights       Date:  2009-10-13

Review 10.  Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease.

Authors:  Lavinia Woodward; Ioannis Akoumianakis; Charalambos Antoniades
Journal:  Br J Pharmacol       Date:  2016-10-19       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.